[1]
Pradip Kumar Sarma, “A Multi-centre Study to Evaluate the Long-Term Efficacy and Safety of Biosimilar Infliximab (Infimab™) in Ankylosing Spondylitis in Real-world Clinical Settings - A perspective from Eastern India”, Int J Med Res Rev, vol. 10, no. 4, pp. 113-121, Aug. 2022.